149 related articles for article (PubMed ID: 32451983)
1. Development of algorithms to estimate EQ-5D and derive health utilities from WHOQOL-HIV Bref: a mapping study.
Castro R; De Boni RB; Perazzo H; Grinsztejn B; Veloso VG; Ribeiro-Alves M
Qual Life Res; 2020 Sep; 29(9):2497-2508. PubMed ID: 32451983
[TBL] [Abstract][Full Text] [Related]
2. Mapping MOS-HIV to HUI3 and EQ-5D-3L in Patients With HIV.
Joyce VR; Sun H; Barnett PG; Bansback N; Griffin SC; Bayoumi AM; Anis AH; Sculpher M; Cameron W; Brown ST; Holodniy M; Owens DK
MDM Policy Pract; 2017; 2(2):2381468317716440. PubMed ID: 30288427
[No Abstract] [Full Text] [Related]
3. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.
Chen G; Garcia-Gordillo MA; Collado-Mateo D; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellán-Perpiñán JM; Sánchez-Martínez FI
Patient; 2018 Dec; 11(6):665-675. PubMed ID: 29876865
[TBL] [Abstract][Full Text] [Related]
4. Obtaining EQ-5D-3L utility index from the health status scale of traditional Chinese medicine (TCM-HSS) based on a mapping study.
Wang L; Lu Y; Dai Z; Shi P; Xu J; Chang F; Lu Y
Health Qual Life Outcomes; 2022 Dec; 20(1):164. PubMed ID: 36522665
[TBL] [Abstract][Full Text] [Related]
5. Mapping EQ-5D utility scores from the PedsQL™ generic core scales.
Khan KA; Petrou S; Rivero-Arias O; Walters SJ; Boyle SE
Pharmacoeconomics; 2014 Jul; 32(7):693-706. PubMed ID: 24715604
[TBL] [Abstract][Full Text] [Related]
6. Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China.
Yang Q; Yu XX; Zhang W; Li H
Health Qual Life Outcomes; 2019 Oct; 17(1):153. PubMed ID: 31615531
[TBL] [Abstract][Full Text] [Related]
7. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
Hawton A; Green C; Telford C; Zajicek J; Wright D
Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
[TBL] [Abstract][Full Text] [Related]
8. Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients.
Khan I; Morris S; Pashayan N; Matata B; Bashir Z; Maguirre J
Health Qual Life Outcomes; 2016 Apr; 14():60. PubMed ID: 27072351
[TBL] [Abstract][Full Text] [Related]
9. Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms.
Doble B; Lorgelly P
Qual Life Res; 2016 Apr; 25(4):891-911. PubMed ID: 26391884
[TBL] [Abstract][Full Text] [Related]
10. Mapping World Health Organization Quality of Life-BREF Onto 5-Level EQ-5D in Thai Patients With Chronic Diseases.
Sakthong P
Value Health; 2021 Aug; 24(8):1089-1094. PubMed ID: 34372973
[TBL] [Abstract][Full Text] [Related]
11. Mean Rank, Equipercentile, and Regression Mapping of World Health Organization Quality of Life Brief (WHOQOL-BREF) to EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Utilities.
Wee HL; Yeo KK; Chong KJ; Khoo EYH; Cheung YB
Med Decis Making; 2018 Apr; 38(3):319-333. PubMed ID: 29587045
[TBL] [Abstract][Full Text] [Related]
12. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K;
Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665
[TBL] [Abstract][Full Text] [Related]
13. Mapping the COPD Assessment Test onto EQ-5D.
Hoyle CK; Tabberer M; Brooks J
Value Health; 2016 Jun; 19(4):469-77. PubMed ID: 27325339
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model.
Franken MD; de Hond A; Degeling K; Punt CJA; Koopman M; Uyl-de Groot CA; Versteegh MM; van Oijen MGH
Health Qual Life Outcomes; 2020 Jul; 18(1):240. PubMed ID: 32690011
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life assessment among people living with HIV in Rio de Janeiro, Brazil: a cross-sectional study.
Castro R; De Boni RB; Luz PM; Velasque L; Lopes LV; Medina-Lara A; Cardoso SW; De Oliveira MS; Friedman RK; Grinsztejn B; Veloso VG
Qual Life Res; 2019 Apr; 28(4):1035-1045. PubMed ID: 30415417
[TBL] [Abstract][Full Text] [Related]
16. Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores.
Kay S; Ferreira A
Ophthalmic Epidemiol; 2014 Apr; 21(2):66-78. PubMed ID: 24568628
[TBL] [Abstract][Full Text] [Related]
17. Mapping the Beck Depression Inventory to the EQ-5D-3L in Patients with Depressive Disorders.
Grochtdreis T; Brettschneider C; Hajek A; Schierz K; Hoyer J; Koenig HH
J Ment Health Policy Econ; 2016 Jun; 19(2):79-89. PubMed ID: 27453455
[TBL] [Abstract][Full Text] [Related]
18. Development of algorithms to estimate the EQ-5D-5L from the FACT-L in patients with lung cancer: a mapping study.
Jiang L; Zhou H; Yang Q; Luo X; Huang D
Qual Life Res; 2024 Mar; 33(3):805-816. PubMed ID: 38148367
[TBL] [Abstract][Full Text] [Related]
19. Health utilities in patients with HIV/AIDS in Thailand.
Sakthong P; Schommer JC; Gross CR; Prasithsirikul W; Sakulbumrungsil R
Value Health; 2009; 12(2):377-84. PubMed ID: 20667064
[TBL] [Abstract][Full Text] [Related]
20. Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis.
Yang F; Wong CKH; Luo N; Piercy J; Moon R; Jackson J
Eur J Health Econ; 2019 Nov; 20(8):1195-1206. PubMed ID: 31338698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
